Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 5/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.41 |
| ▸ | QPCT | Q16769 | 2/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.39 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28843269 | 0.91 | TBXAS1 (0.47) | TBXAS1CYP11B1CYP11B2CYP19A1CYP17A1 | |
| SCHEMBL13919194 | 0.87 | TBXAS1 (0.45) | TBXAS1CYP11B1CYP11B2CYP19A1CYP17A1 | |
| SCHEMBL19785772 | 0.86 | TBXAS1 (0.44) | TBXAS1CYP11B1CYP11B2CYP19A1CYP17A1 | |
| SCHEMBL4338960 | 0.84 | TBXAS1 (0.49) | TBXAS1CYP11B1CYP11B2CYP19A1CYP17A1 | |
| SCHEMBL14415940 | 0.83 | TBXAS1 (0.53) | TBXAS1CYP11B1CYP11B2CYP19A1CYP17A1 | |
| Hydrochloric Acid SCHEMBL28328253 | 0.82 | TBXAS1 (0.50) | TBXAS1CYP11B1CYP11B2CYP19A1CYP17A1 | |
| SCHEMBL26660791 | 0.82 | TBXAS1 (0.51) | TBXAS1CYP11B1CYP11B2CYP19A1CYP17A1 | |
| SCHEMBL21361846 | 0.82 | TBXAS1 (0.47) | TBXAS1CYP11B1CYP11B2CYP19A1CYP17A1 | |
| Iodide SCHEMBL27677678 | 0.82 | TBXAS1 (0.47) | TBXAS1CYP11B1CYP11B2CYP19A1CYP17A1 | |
| Bromide SCHEMBL28286964 | 0.82 | TBXAS1 (0.47) | TBXAS1CYP11B1CYP11B2CYP19A1CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116162112-A | N-heterocyclic carbene type cyclometalated platinum complex of oxidized iso-aporphine alkaloid and synthetic method and application thereof | 广西师范大学 | 2023-05-26 | — | — | CN | claimed |
| CN-116162112-A | N-heterocyclic carbene type cyclometalated platinum complex of oxidized iso-aporphine alkaloid and synthetic method and application thereof | 广西师范大学 | 2023-05-26 | — | — | CN | disclosed |
| CN-116162112-A | N-heterocyclic carbene type cyclometalated platinum complex of oxidized iso-aporphine alkaloid and synthetic method and application thereof | 广西师范大学 | 2023-05-26 | — | — | CN | disclosed |
| US-20190292450-A1 | Precursor Based Method of Synthesis and Fabrication of Hybrid Lighting Phosphors with High Quantum Efficiency, and Significantly Enhanced Thermal and Photostability | NATIONAL SCIENCE FOUNDATION | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292450-A1 | Precursor Based Method of Synthesis and Fabrication of Hybrid Lighting Phosphors with High Quantum Efficiency, and Significantly Enhanced Thermal and Photostability | DCX, ZKSCAN2, CAD | TBXAS1 3949/4885CYP11B1 4772/4885CYP11B2 4657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.